LINCOLN NATIONAL CORP – Edwards Lifesciences Corporation Transaction History
LINCOLN NATIONAL CORP portfolio value:
$2.20M
portfolio value
LINCOLN NATIONAL CORP quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +4.34% | 1.11K shares | -227K | $82.63 | 26.72K |
| Q2 2022 | share | Increase | +0.46% | 117 shares | -565K | $95.09 | 25.61K |
| Q1 2022 | share | Decrease | -1.72% | -447 shares | -360K | $117.72 | 25.49K |
| Q4 2021 | share | Decrease | -1.87% | -494 shares | 368K | $130.68 | 25.94K |
| Q3 2021 | share | Increase | +2.34% | 604 shares | 318K | $113.21 | 26.43K |
| Q2 2021 | share | Increase | +10.42% | 2.43K shares | 718K | $103.57 | 25.83K |
| Q1 2021 | share | Decrease | -10.57% | -2.76K shares | -429K | $83.64 | 23.39K |
| Q4 2020 | share | Increase | +5.51% | 1.36K shares | 407K | $91.23 | 26.15K |
| Q3 2020 | share | Increase | +7.55% | 1.74K shares | 386K | $79.82 | 24.79K |
| Q2 2020 | share | Increase | +1.97% | 445 shares | 172K | $69.11 | 23.05K |
| Q1 2020 | share | Increase | +14.53% | 2.86K shares | -114K | $62.87 | 22.60K |
| Q4 2019 | share | Increase | +49.39% | 6.52K shares | 566K | $77.76 | 19.73K |
| Q3 2019 | share | Increase | +3.55% | 453 shares | 183K | $73.3 | 13.21K |
| Q2 2019 | share | Increase | 0.00% | 12.75K shares | 786K | $61.58 | 12.75K |
| Q1 2019 | share | Decrease | -100.00% | -7.58K shares | -387K | $63.78 | 0 |
| Q4 2018 | share | Increase | +37.60% | 2.07K shares | 67K | $51.06 | 7.58K |
| Q3 2018 | share | Increase | +3.14% | 168 shares | 61K | $58.03 | 5.51K |
| Q2 2018 | share | Increase | +12.43% | 591 shares | 38K | $48.52 | 5.34K |
| Q1 2018 | share | Decrease | -43.55% | -3.66K shares | -95K | $46.51 | 4.75K |
| Q4 2017 | share | Increase | 0.00% | 8.42K shares | 316K | $37.57 | 8.42K |